Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Tenapanor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ardelyx Presents XPHOZAH Long-Term Safety at NKF Spring Meetings
    Ardelyx Presents XPHOZAH Long-Term Safety at NKF Spring Meetings

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3289968/0/en/ardelyx-presents-analysis-supporting-long-term-safety-of-xphozah-at-nkf-s-spring-clinical-meetings.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Ardelyx To Present Poster At NKF Spring Clinical Meetings
    Ardelyx To Present Poster At NKF Spring Clinical Meetings

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281589/0/en/ardelyx-announces-abstract-accepted-for-poster-presentation-at-the-nkf-s-spring-clinical-meetings.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Ardelyx Reveals Tenapanor's Rapid Symptom Relief In IBS-C Review
    Ardelyx Reveals Tenapanor's Rapid Symptom Relief In IBS-C Review

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252292/0/en/Ardelyx-Announces-Publication-of-a-Review-Article-Demonstrating-Rapid-and-Meaningful-Symptom-Relief-with-Tenapanor-in-IBS-C.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Ardelyx Receives New Patent For Tenapanor
    Ardelyx Receives New Patent For Tenapanor

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231070/0/en/Ardelyx-Receives-New-Patent-for-Tenapanor.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    First Patient Dosed in Phase 3 ACCEL Study of IBSRELA
    First Patient Dosed in Phase 3 ACCEL Study of IBSRELA

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227602/0/en/First-Patient-Dosed-in-ACCEL-Phase-3-Chronic-Idiopathic-Constipation-Study-of-IBSRELA.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    XPHOZAH Data Shows Patient Satisfaction And Phosphate Drop
    XPHOZAH Data Shows Patient Satisfaction And Phosphate Drop

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183960/0/en/Real-World-Evidence-Studies-of-XPHOZAH-tenapanor-Demonstrate-Patient-Satisfaction-and-Reduction-in-Serum-Phosphate-with-XPHOZAH-in-Data-Presented-at-ASN-Kidney-Week.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.